Nicotinamide adenine dinucleotide 3-pentanone adduct

Star0

DB04421ExperimentalSmall molecule

Nicotinamide adenine dinucleotide 3-pentanone adduct: Overview.

Formula / weight: C₂₆H₃₅N₇O₁₅P₂ · 747.5415 g/mol (avg)

Resolves to

Compound

PubChem131704281

Structure

InChIKeyBZJFKYRGSZWSLT-YLIVDTKOSA-NSMILES

CCC(=O)[C@@H](C)C1=C(C=[N+](C=C1)[C@@H]1O[C@H](COP(O)(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O)C(N)=O

Which companies are running trials of Nicotinamide adenine dinucleotide 3-pentanone adduct, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account